MorphoSys AG is a biotechnology business based in the US. MorphoSys shares (MOR) are listed on the NASDAQ and all prices are listed in US Dollars. MorphoSys employs 609 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in MorphoSys
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MOR – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
MorphoSys stock price (NASDAQ: MOR)Use our graph to track the performance of MOR stocks over time.
MorphoSys shares at a glance
|Latest market close||$22.08|
|52-week range||$15.92 - $34.99|
|50-day moving average||$19.23|
|200-day moving average||$23.41|
|Wall St. target price||$30.55|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.90|
Buy MorphoSys shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy MorphoSys stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
MorphoSys price performance over time
|1 week (2021-07-16)||N/A|
|1 month (2021-06-25)||11.40%|
|3 months (2021-04-27)||-3.75%|
|6 months (2021-01-23)||N/A|
|1 year (2020-07-23)||N/A|
|2 years (2019-07-23)||N/A|
|3 years (2018-07-23)||N/A|
|5 years (2016-07-23)||N/A|
Is MorphoSys under- or over-valued?
Valuing MorphoSys stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of MorphoSys's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
MorphoSys's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $38.7 million.
The EBITDA is a measure of a MorphoSys's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$123.7 million|
|Gross profit TTM||$318.5 million|
|Return on assets TTM||-8.3%|
|Return on equity TTM||-22.31%|
|Market capitalisation||$2.1 billion|
TTM: trailing 12 months
Shorting MorphoSys shares
There are currently 163,921 MorphoSys shares held short by investors – that's known as MorphoSys's "short interest". This figure is 31.9% up from 124,266 last month.
There are a few different ways that this level of interest in shorting MorphoSys shares can be evaluated.
MorphoSys's "short interest ratio" (SIR)
MorphoSys's "short interest ratio" (SIR) is the quantity of MorphoSys shares currently shorted divided by the average quantity of MorphoSys shares traded daily (recently around 202371.60493827). MorphoSys's SIR currently stands at 0.81. In other words for every 100,000 MorphoSys shares traded daily on the market, roughly 810 shares are currently held short.
However MorphoSys's short interest can also be evaluated against the total number of MorphoSys shares, or, against the total number of tradable MorphoSys shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case MorphoSys's short interest could be expressed as 0% of the outstanding shares (for every 100,000 MorphoSys shares in existence, roughly 0 shares are currently held short) or 0.0013% of the tradable shares (for every 100,000 tradable MorphoSys shares, roughly 1 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against MorphoSys.
Find out more about how you can short MorphoSys stock.
MorphoSys share dividends
We're not expecting MorphoSys to pay a dividend over the next 12 months.
MorphoSys share price volatility
Over the last 12 months, MorphoSys's shares have ranged in value from as little as $15.92 up to $34.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while MorphoSys's is 0.7289. This would suggest that MorphoSys's shares are less volatile than average (for this exchange).
MorphoSys AG, together with its subsidiaries, discovers, develops and commercializes therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. Its lead product candidate is Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B cell lymphoma and chronic lymphocytic leukemia. The company develops Tremfya, an antibody to treat plaque psoriasis, psoriatic arthritis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, and adenomatous polyposis diseases; Gantenerumab, an antibody for the treatment of Alzheimer's diseases through its pharmaceutical partners; Otilimab, an antibody for rheumatoid arthritis; and MOR106, an antibody for atopic dermatitis. It also develops Felzartamab, an antibody directed against CD38, which is in Phase I/II clinical trials for the treatment of anti-PLA2R-positive membranous nephropathy, an autoimmune disease. MorphoSys AG has a regional licensing agreement with I-Mab Biopharma to develop and commercialize felzartamab in China, Taiwan, Hong Kong, and Macau; a strategic alliance with the LEO Pharma; a joint collaboration and license agreement with Incyte Corporation for the development and commercialization of MorphoSys investigational compound tafasitamab (MOR208); and a clinical collaboration with Incyte Corporation and Xencor, Inc. to investigate the combination of tafasitamab, plamotamab, and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma, and relapsed or refractory follicular lymphoma. The company was founded in 1992 and is headquartered in Planegg, Germany.
Stocks similar to MorphoSys
MorphoSys in the news
48 Stocks Moving In Monday's Mid-Day Session
Stocks That Hit 52-Week Lows On Monday
MorphoSys Stock Falls After Trimming Upper End Of 2021 Revenue Outlook
Frequently asked questionsWhat percentage of MorphoSys is owned by institutions?
Currently 2.139% of MorphoSys shares are held by institutions. How many people work for MorphoSys?
Latest data suggests 609 work at MorphoSys. When does the fiscal year end for MorphoSys?
MorphoSys's fiscal year ends in December. Where is MorphoSys based?
MorphoSys's address is: Semmelweisstrasse 7, Planegg, Germany, 82152 What is MorphoSys's ISIN number?
MorphoSys's international securities identification number is: US6177602025 What is MorphoSys's CUSIP number?
MorphoSys's Committee on Uniform Securities Identification Procedures number is: 617760202
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert